What is the appropriate evaluation and management for a patient who develops fever one week after coronary stent placement?

Fever 1 Week After Coronary Stent: Evaluation and Management

Coronary stent infection must be considered immediately in any patient presenting with fever within the first few weeks after PCI, as this rare but catastrophic complication carries a 30% in-hospital mortality rate and requires urgent multimodality imaging and aggressive management 1.

Clinical Presentation and Timing

Fever developing one week post-stent placement falls within the highest-risk window for stent infection. Most patients (43%) present within the first week after PCI 1. Key clinical features include:

• Fever (72% of cases) - the most common presenting symptom 1
• Chest pain - present in 38% as acute coronary syndrome 2, 3
• Persistent bacteremia despite appropriate antibiotics
• Constitutional symptoms - weight loss, recurrent fevers 4

Immediate Diagnostic Workup

Blood Cultures and Microbiology

• Obtain at least 2-3 sets of blood cultures immediately before starting antibiotics
• Staphylococcus aureus is the causative organism in 65% of cases 1, with methicillin-sensitive S. aureus being common 2
• Positive blood cultures occur in approximately 60% of cases 5

Multimodality Imaging Protocol

1. Coronary Angiography (First-line)

• Mycotic aneurysms or pseudoaneurysms are present in 62% of stent infections 1
• Angiography can demonstrate contrast extravasation, filling defects, or aneurysmal dilation at the stent site 2, 3

2. Cardiac CT with Contrast

• Superior for anatomical definition of pseudoaneurysms and surrounding structures 5
• Can detect stent separation and abscess formation 6

3. PET-CT Imaging

• Shows FDG uptake at the stent site in infected cases 6, 7
• Important caveat: PET-CT can be nondiagnostic or false-negative 5, so negative results do not exclude infection

4. Transthoracic/Transesophageal Echocardiography

• Evaluate for vegetations, fistula formation, and left atrial appendage involvement 2
• TEE is more sensitive for detecting complications

Risk Factors to Assess

• Type 2 diabetes mellitus (present in 35% of cases) 1
• Structural heart disease - strongly predicts in-hospital mortality (83% mortality vs 17% survival, p=0.009) 1
• NSTE-ACS presentation - paradoxically associated with better survival (11% mortality vs 88% survival, p=0.03) 1

Management Algorithm

Immediate Actions (Day 1)

1. Start empiric IV antibiotics immediately after blood cultures

   • Cover S. aureus with vancomycin 15-20 mg/kg IV q8-12h (adjust for renal function)
   • Consider adding gram-negative coverage if septic or immunocompromised

2. Continue dual antiplatelet therapy (DAPT) unless life-threatening bleeding

   • Aspirin 75-100 mg daily 8, 9
   • Clopidogrel 75 mg daily 8, 9
   • Do NOT stop DAPT prematurely - this increases catastrophic stent thrombosis risk

3. Urgent cardiology and cardiac surgery consultation

Definitive Management Decision (Days 2-5)

Surgical Intervention (Preferred)

• Stent explantation, abscess drainage, and coronary artery bypass grafting is the definitive treatment 2, 6, 3, 5
• Indicated for:
  • Confirmed or highly suspected stent infection
  • Presence of mycotic aneurysm/pseudoaneurysm
  • Persistent bacteremia despite antibiotics
  • Hemodynamic instability

Medical Management Alone (High-Risk Surgical Candidates)

• Prolonged IV antibiotics (minimum 4-6 weeks) similar to endocarditis treatment 10, 11
• Consider in patients with:
  • Prohibitive surgical risk
  • Delayed presentation with stable pseudoaneurysm
  • Negative imaging but persistent clinical suspicion
• Patients from specialized centers had 80% survival with medical therapy alone 1, but this requires close monitoring

Antibiotic Duration

If Surgery Performed:

• Minimum 4-6 weeks of pathogen-directed IV antibiotics post-operatively 10, 7
• Adjust based on intraoperative cultures and sensitivities

If Medical Management Only:

• 6 weeks minimum of IV antibiotics 4, 7
• For resistant organisms (e.g., M. abscessus): up to 6 months of multidrug therapy 7

Critical Pitfalls to Avoid

1. Delaying diagnosis - High index of suspicion is essential; don't wait for positive cultures to start imaging
2. Stopping DAPT - Premature discontinuation risks stent thrombosis on top of infection
3. Relying solely on PET-CT - Can be falsely negative 5
4. Delaying surgical consultation - Mortality increases with delayed intervention, especially in elderly patients 5
5. Inadequate antibiotic duration - Treat like endocarditis (4-6 weeks minimum)

Prognosis

• Overall in-hospital mortality: 30.3% 1
• Elderly patients with delayed presentation and hemodynamic compromise have the worst outcomes 5
• Early recognition and timely surgical intervention significantly improve survival 3, 5

Differential Considerations

While evaluating for stent infection, also consider:

• Post-PCI pericarditis (Dressler syndrome)
• Catheter-related bloodstream infection from access site
• Unrelated infectious process
• Drug fever

However, given the catastrophic consequences of missed stent infection, maintain a low threshold for advanced imaging and aggressive management 2, 3.